BMS-986315

· Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BMS-986315, covering 2025-04-16 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing